Gastrointestinal parameters that influence oral medications.
暂无分享,去创建一个
W. Ritschel | J. Dressman | E. Ziv | P. Bass | D. Friend | A. Rubinstein
[1] A. Sintov,et al. Chondroitin sulfate: A potential biodegradable carrier for colon-specific drug delivery , 1992 .
[2] A. Macpherson,et al. Glucose and citrate reduce the permeability changes caused by indomethacin in humans. , 1992, Gastroenterology.
[3] B. Korelitz. Where Do We Stand on Drug Treatment for Ulcerative Colitis? , 1992, Annals of Internal Medicine.
[4] N. Miyata,et al. Evaluation of pH-independent sustained-release granules of dipyridamole by using gastric-acidity-controlled rabbits and human subjects , 1992 .
[5] M. Ström,et al. Pharmacokinetics of Tranexamic Acid in Patients with Ulcerative Colitis and in Healthy Volunteers After the Single Instillation of 2 g Rectally , 1992, Journal of clinical pharmacology.
[6] W. Curatolo,et al. C) Means to enhance penetration , 1992 .
[7] D. Fleisher,et al. Influence of D-glucose-induced water absorption on rat jejunal uptake of two passively absorbed drugs. , 1992, Journal of pharmaceutical sciences.
[8] W. Ritschel,et al. Peroral absorption of cefroxadine in patients within the first day after severe trauma: comparison to cefroxadine pharmacokinetics in fasted, healthy volunteers. , 1991, Methods and Findings in Experimental and Clinical Pharmacology.
[9] D. Friend. Colon-specific drug delivery , 1991 .
[10] P. Gwilt,et al. The Effects of Diabetes Mellitus on Pharmacokinetics and Pharmacodynamics in Humans , 1991, Clinical pharmacokinetics.
[11] Jerome J. Schentag,et al. Increased gastric pH and the bioavailability of fluconazole and ketoconazole. , 1991, Annals of Internal Medicine.
[12] T. Tozer,et al. Relative anti‐inflammatory effect of oral dexamethasone‐β‐D‐glucoside and dexamethasone in experimental inflammatory bowel disease in guinea‐pigs , 1991, The Journal of pharmacy and pharmacology.
[13] J. Hanker,et al. Gastrointestinal disease and oral contraception , 1990, American Journal of Obstetrics and Gynecology.
[14] A. Rubinstein. Microbially controlled drug delivery to the colon , 1990, Biopharmaceutics & drug disposition.
[15] C. MacArthur,et al. Misoprostol provides a colonic mucosal protective effect during acetic acid-induced colitis in rats. , 1990, Gastroenterology.
[16] R. Roser,et al. The Influence of Gastric Emptying on Droxicam Pharmacokinetics , 1989, Journal of clinical pharmacology.
[17] W. Heizer,et al. Effect of Altering Small Bowel Transit Time on Sustained Release Theophylline Absorption , 1989, Journal of clinical pharmacology.
[18] G. Kearns,et al. Clinical Pharmacokinetics in Infants and Children , 1989, Clinical pharmacokinetics.
[19] J. Dressman,et al. Elevation of gastric pH with ranitidine does not affect the release characteristics of sustained release ibuprofen tablets , 1988, Biopharmaceutics & drug disposition.
[20] E. Ziv,et al. Absorption of protein via the intestinal wall. A quantitative model. , 1987, Biochemical Pharmacology.
[21] D. Neckers,et al. A new approach to the oral administration of insulin and other peptide drugs. , 1986, Science.
[22] D. Friend,et al. Drug glycosides: potential prodrugs for colon-specific drug delivery. , 1985, Journal of medicinal chemistry.
[23] D. Friend,et al. A colon-specific drug-delivery system based on drug glycosides and the glycosidases of colonic bacteria. , 1984, Journal of medicinal chemistry.
[24] M. Bendayan. Protein A‐gold electron microscopic immunocytochemistry: Methods, applications, and limitations , 1984 .
[25] P. Bass,et al. Mechanisms of Action of Laxative Drugs , 1984 .
[26] A. Onderdonk,et al. A polymeric drug for treatment of inflammatory bowel disease. , 1983, Journal of medicinal chemistry.
[27] E. Berry,et al. The absorption of insulin from various regions of the rat intestine. , 1982, Life sciences.
[28] P. Bass,et al. Laxative-like effects of nonsteroidal anti-inflammatory drugs on intestinal fluid movement and membrane integrity. , 1982, Journal of Pharmacology and Experimental Therapeutics.
[29] E. Berry,et al. Bile salts promote the absorption of insulin from the rat colon. , 1981, Life sciences.
[30] M. Kendall,et al. Effects of inflammatory disease on plasma oxprenolol concentrations. , 1979, British medical journal.
[31] C. Hawkins,et al. Plasma propranolol concentrations and the erythrocyte sedimentation rate. , 1979, British Journal of Clinical Pharmacology.
[32] D. Southgate,et al. The digestion of pectin in the human gut and its effect on calcium absorption and large bowel function , 1979, British Journal of Nutrition.
[33] B. Beermann,et al. Malabsorption of Hydrochlorothiazide Following Intestinal Shunt Surgery , 1979, Clinical pharmacokinetics.
[34] F. Sjöqvist,et al. Increased plasma protein binding of propranolol and chlorpromazine mediated by disease-induced elevations of plasma alpha1 acid glycoprotein. , 1978, The New England journal of medicine.
[35] P. Bass,et al. Laxatives: an update on mechanism of action. , 1978, Life sciences.
[36] T. Gaginella,et al. Perfusion of rabbit colon with ricinoleic acid: dose-related mucosal injury, fluid secretion, and increased permeability. , 1977, Gastroenterology.
[37] V. Go,et al. Cytotoxicity of ricinoleic acid (castor oil) and other intestinal secretagogues on isolated intestinal epithelial cells. , 1977, Journal of Pharmacology and Experimental Therapeutics.
[38] B. Creamer,et al. Plasma levels and intestinal absorption of 25-hydroxyvitamin D in patients with small bowel resection. , 1977, Gut.
[39] G. Greisen,et al. Drug absorption and hepatic drug metabolism in patients with different types of intestinal shunt operation for obesity. A study with phenazone. , 1977, Scandinavian Journal of Gastroenterology.
[40] R. Parsons. Drug Absorption in Gastrointestinal Disease With Particular Reference to Malabsorption Syndromes , 1977, Clinical pharmacokinetics.
[41] J. Kral,et al. Oral contraceptives after intestinal bypass operations. , 1976, Journal of the American Medical Association (JAMA).
[42] M. Mitchard,et al. Plasma levels of propranolol in treated patients with coeliac disease and patients with Crohn's disease. , 1976, British medical journal.
[43] P. Bass,et al. The effects of sodium ricinoleate on small intestinal function and structure. , 1976, The Journal of clinical investigation.
[44] P. Bass,et al. Effects of ricinoleic and oleic acids on the digestive contractile activity of the canine small and large bowel. , 1976, Gastroenterology.
[45] W. Nimmo. Drugs, Diseases and Altered Gastric Emptying , 1976, Clinical pharmacokinetics.
[46] P. Bass,et al. Actions of ricinoleic acid and structurally related fatty acids of the gastrointestinal tract. I. Effects on smooth muscle contractility in vitro. , 1975, Journal of Pharmacology and Experimental Therapeutics.
[47] R. Parsons,et al. Absorption of two antibacterial drugs, cephalexin and co-trimoxazole, in malabsorption syndromes. , 1975, Journal of Antimicrobial Chemotherapy.
[48] P. Bass,et al. Inhibition of small intestinal mucosal and smooth muscle cell function by ricinoleic acid and other surfactants. , 1975, Life sciences.
[49] R. Parsons,et al. The absorption of antibiotics in adult patients with coeliac disease. , 1975, Journal of Antimicrobial Chemotherapy.
[50] P. Bass,et al. Inhibitory actions of laxatives on motility and water and electrolyte transport in the gastrointestinal tract. , 1975, The Journal of pharmacology and experimental therapeutics.
[51] L. Prescott,et al. The absorption of aspirin and paracetamol in patients with achlorhydria , 1974, The Journal of pharmacy and pharmacology.
[52] M. Kristensen,et al. The clinical effect of salazosulphapyridine (Salazopyrin r) in Crohn's disease. A controlled double-blind study. , 1974, Scandinavian journal of gastroenterology.
[53] J. Nelson,et al. Absorption of ampicillin and nalidixic acid by infants and children with acute shigellosis , 1972, Clinical pharmacology and therapy.
[54] B. Drasar,et al. Intestinal bacteria and the hydrolysis of glycosidic bonds. , 1971, Journal of medical microbiology.
[55] P. Toghill,et al. Folate deficiency and the pill. , 1971, British medical journal.
[56] J. Hardcastle,et al. The action of sennosides and related compounds on human colon and rectum 1 , 1970, Gut.
[57] C. V. Winder,et al. Relationship of the enterohepatic cycle to ulcerogenesis in the rat small bowel with flufenamic acid. , 1970, Gastroenterology.
[58] B. Morris,et al. The response of the hepatic lymph node of the sheep to swine influenza virus. , 1970, Australian Journal of Experimental Biology and Medical Science.
[59] A. Tappel,et al. LYSOSOMAL ENZYMES AND MUCOPOLYSACCHARIDES IN THE GASTRO-INTESTINAL TRACT OF THE RAT AND PIG. , 1965, Biochimica et biophysica acta.
[60] A. Tappel,et al. LYSOSOMAL ENZYMES OF RAT INTESTINAL MUCOSA , 1964, Journal of Cell Biology.
[61] Smith Rs. IRON ABSORPTION IN CYSTIC FIBROSIS. , 1964 .
[62] M. Grossman,et al. Fecal blood loss produced by oral and intravenous administration of various salicylates. , 1961, Gastroenterology.
[63] D. Macdonald,et al. Glycosidases in the Mammalian Alimentary Tract , 1959, Nature.
[64] A. Ivy,et al. On the fate of ingested pectin. , 1941 .